Elie Richa, MD
Clinical Associate-Blood Bank
Contact
Department of Pathology
The University of Chicago
5841 S. Maryland Avenue, MC 0007
Chicago, IL 60637-1470
Phone: (773) 702-7176
Fax: (773) 702-4543
elie.richa@uchospitals.edu
Language Fluency
English - Arabic - FrenchCommittee Membership
Member of Hematopoietic Progenitor Cell Donor Subcommittee for American Society for Apheresis (ASFA)
Assessor- The American Association Blood Banks Accreditation (in training)
Clinical Interest
Blood Bank/ TransfusionResearch Interests
- Safety of blood transfusion as well as blood donors
- Therapeutic plasmapheresis
- Stem cells collection and infusion
- Richa E, Padley D, Stowers R, Charrette T, Grenier C and Gastineau D. Factors contributing to renal failure in patients undergoing stem cell transplant for multiple myeloma and primary amyloidosis Poster presentation at ISCT meeting June 2007, Sydney Australia
- Richa E, Burgastler E, Greiner C, Bryant S, and Winters J. Incidence of Platelets Counts and Platelet Units Transfused in the Stem Collection on Amicus versus Spectra Apheresis Automated Cell Seperator in non Hodgkin’s Lymphoma Submitted to J of Clin Apher
- Richa E, Burgastler E, Bryant S, Kruguer P and Winters J. The effects of double and triple apheresis platelet product donation on apheresis platelet donor and white blood cell counts In press Transfusion
- Stowers R, Richa E, Stubbs J and Moore B. A case report of red blood cell transfusion in a patient with anti-AnWj ImmunoHematol Vol. 23, No. 2, 2007
- Badine E, Richa E, El-Sayah D and Terjanian T. A case report of splenic rupture due to marginal zone lymphoma Ann Hematol. 2007 pending publication
- Richa E, Benidt G, Tauscher C, Stowers R, Van Valkenburg J and Stubbs J The safety of electronic cross-match in Patients with Warm Auto Antibodies Vox sanguinis 2007;93:92
- Richa E, Benidt G,Tauscher C, Stowers R, Bryant S and Stubbs J The Utility of Eluate Testing Following Microscopically Positive Direct Antiglobulin Test with anti-IgG (Micro-Positive DATs), Clin Lab Sci 2007;37:167-69
- Odaimi M, El-Jassous I, Richa E, Forte F, Terjanian T, Vesoniaraki M, Lowry J, Murukutla S, Dhar M and Burton J. Phase I/II trial of a novel regimen of GM-CSF, IL-2 and pegylated interferon-alpha2b (PEG-Intron) for stage IV melanoma and renal cell carcinoma. J CLIN ONCOL. 22 (14): 728S
Selected Publications
The University of Chicago · 5841 S. Maryland Avenue · Chicago, IL 60637
773.702.0647 · webmaster@pathology.bsd.uchicago.edu